Fall speaking schedule delivers opportunities to hear from ivWatch experts and end-users
HAMPTON, Va., August 23, 2018 – Representatives and customers of ivWatch, the only provider of continuous monitoring devices for the early detection of intravenous (IV) infiltrations and extravasations, will share their experience and discuss current projects at several upcoming association events in multiple health care segments including vascular access, pediatrics and person-centered care.
- On September 14, panelists from Cincinnati Children’s Hospital and Medical Center will participate in a pre-conference symposium at the Association for Vascular Access (AVA) 2018 Annual Scientific Meeting. Sylvia Rineair MSHA, BSN, RN, VA-BC, clinical director of the Vascular Access Team will be joined by Lindsay Cipriani MSN, RN, M. Ed., an education specialist in the Pediatric Intensive Care Unit (PICU), to discuss a quality improvement project using the ivWatch Model 400 for early detection of peripheral IV complications.
- On September 18, ivWatch Chief Nursing Officer, Susan Brown MSN, MSED, VA-BC, will facilitate a session at AVA’s 2018 Annual Scientific Meeting titled, “Improve Early Detection of Infiltration and Extravasation Events: Training Non-Vascular Access Team Members on Proven Methods, Protocols, and Technology.”
- On September 26, all interested parties can register to hear from leaders at Cincinnati Children’s Hospital Medical Center during the webinar, “Paving the Way: Early Detection Technology – PIVIE Harm Reduction” hosted by the Children’s Hospital Association (CHA).
- On September 28-29, Brown will present at the Emergency Nurses Association (ENA) Annual Conference on “IV Infiltration and Extravasation Risks and Early Detection” covering required skills and tools in the emergency setting for IV therapy care from intake to discharge/transfer.
- On October 9, Brown will present at the Planetree International Conference on Person-Centered Care. She will discuss improving patient experiences during the session “New Standard of Care for PIVs, Improving Patient Outcomes by Early Detection of Infiltrations for High-Risk Patients.”
“I am thrilled to have been accepted to speak at some of the medical industry’s best trade shows to share what I’ve learned throughout my career, educate future leaders on the new advancements in vascular access, as well as promote the successes of our customers and the quality improvements offered to their patients,” said Brown, whose clinical background is in pediatrics. “Every opportunity we have to speak to hospital leadership and the nurses on the frontlines, the closer we are to keeping more people safe from preventable IV harm.”
Infiltration studies are available, and the awareness of the issue is growing, yet, it remains an underreported occurrence. ivWatch is committed to education on the prevalence of IV complications, identifying the risks of infiltration, assessment methods and how ivWatch technology fits into clinical workflows to improve patient safety and outcomes. The company also sponsors a website that focuses on simplified IV information, myIV.com, which provides resources to medical staff for their patients.
To learn more about ivWatch and upcoming event participation, visit www.ivWatch.com/events/.
ivWatch, LLC is the leading medical device manufacturer and biosensor technology company focused on improving patient safety and the effectiveness of intravenous therapy. Our dedicated and passionate team is focused on our company vision of eliminating patient harm caused by infiltrations and extravasations. Through our innovative monitored IV solutions, we help minimize the risks associated with adverse IV events. Follow us on Twitter @ivWatch or Facebook @ivWatchLLC. https://www.ivwatch.com/
MEDIA CONTACT: Amara Betoney, email@example.com, Direct (757) 224-2606, Office (855) 489-2824 x7007, Mobile (757) 660-4949